Lance Heilbrun Selected Research

Androgens

1/2012	Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
1/2012	Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lance Heilbrun Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2012
6	Neoplasms (Cancer) 11/2023 - 08/2012
2	Neutropenia 01/2018 - 12/2015
2	Neoplasm Metastasis (Metastasis) 04/2013 - 01/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023
1	Heart Diseases (Heart Disease) 11/2023
1	7 Hereditary Prostate Cancer 01/2018
1	Hyperglycemia 01/2018
1	Thrombocytopenia (Thrombopenia) 12/2015
1	Squamous Cell Carcinoma of Head and Neck 04/2015
1	Disease Progression 04/2015
1	Triple Negative Breast Neoplasms 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2012
1	Adenocarcinoma 08/2012
1	Carcinogenesis 08/2012
1	Renal Insufficiency (Renal Failure) 08/2009
1	Kidney Diseases (Kidney Disease) 08/2009
1	Kidney Neoplasms (Kidney Cancer) 08/2009
1	Chronic Renal Insufficiency 08/2009

Drug/Important Bio-Agent (IBA)

3	Prednisone (Sone)FDA LinkGeneric 01/2019 - 12/2015
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 04/2013
3	Docetaxel (Taxotere)FDA Link 01/2019 - 12/2015
2	CreatinineIBA 11/2023 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2015 - 08/2012
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 04/2013
2	AndrogensIBA 01/2012 - 01/2012
1	NivolumabIBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	cediranib (AZD2171)IBA 01/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	pasireotideIBA 01/2018
1	Everolimus FDA Link 12/2015
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	Gemcitabine FDA Link 04/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2015
1	Complementary DNA (cDNA)IBA 01/2015
1	veliparibIBA 01/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015
1	Serine Proteases (Serine Protease)IBA 04/2013
1	EnzymesIBA 04/2013
1	Chymotrypsin FDA Link 04/2013
1	Galectin 3 (LGALS3)IBA 04/2013
1	ParaffinIBA 08/2012
1	Formaldehyde (Formol)FDA Link 08/2012
1	Capecitabine (Xeloda)FDA Link 08/2012
1	Celecoxib (Celebrex)FDA Link 08/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2012
1	Androgen Receptors (Androgen Receptor)IBA 01/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	Sorafenib (BAY 43-9006)FDA Link 08/2009
1	raf KinasesIBA 08/2009

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2023 - 08/2012
4	Therapeutics 01/2018 - 08/2009
1	Radiotherapy 11/2023
1	Castration 12/2015